Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway-Reference-Cited by-同舟云学术

Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway

Published:2017-12-12 Issue:69 Volume:8 Page:114123-114135
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Guo Kevin Y.¹²,Han Lili¹³,Li Xinyu²,Yang Andrew V.²,Lu Jiaxiong²,Guan Shan²,Li Hui¹,Yu Yang²,Zhao Yanling²,Yang Jianhua²,Zhang Hong¹⁴

Affiliation:

1. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

2. Texas Children’s Cancer Center, Department of Pediatrics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA

3. Department of Gynecology, People’s Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, Xinjiang 830001, China

4. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Proteasome Inhibitor Marizomib Evokes Endoplasmic Reticulum Stress and Promotes Apoptosis in Human Glioblastoma Cells;Pharmaceuticals;2024-08-20

2. Proteasome inhibitors as anticancer agents;Expert Opinion on Therapeutic Patents;2023-10-30

3. DNMT2/TRDMT1 gene knockout compromises doxorubicin-induced unfolded protein response and sensitizes cancer cells to ER stress-induced apoptosis;Apoptosis;2022-10-23

4. LINC00511 promotes cervical cancer progression by regulating the miR-497-5p/MAPK1 axis;Apoptosis;2022-09-14

5. Combined treatment of marizomib and cisplatin modulates cervical cancer growth and invasion and enhances antitumor potential in vitro and in vivo;Frontiers in Oncology;2022-08-30